Guanhao Biotech Co Ltd Cash Flow Conversion Efficiency

Latest as of December 2025: 0.037x

Guanhao Biotech Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Guanhao Biotech Co Ltd (300238) has a cash flow conversion efficiency ratio of 0.037x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥18.84 Million ≈ $2.76 Million USD) by net assets (CN¥506.03 Million ≈ $74.05 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Guanhao Biotech Co Ltd (2007–2025)

Cash flow conversion efficiency of Guanhao Biotech Co Ltd from 2007 to 2025. This chart illustrates how Guanhao Biotech Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Guanhao Biotech Co Ltd (300238) stock price for real-time trading data and today's change.

Guanhao Biotech Co Ltd Cash Flow Conversion Ratio Explained

Guanhao Biotech Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Guanhao Biotech Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Guanhao Biotech Co Ltd ranked by their cash flow conversion efficiency. Also see market cap of Guanhao Biotech Co Ltd for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Fulgent Sun International Holding Co Ltd
TW:9802
-0.061x
Shenzhen Jiang and Associates Creative Design Co Ltd
SHE:300668
0.019x
Fujian Tendering Co. Ltd.
SHE:301136
N/A
Borosil Limited
NSE:BOROLTD
0.059x
Cambi ASA
OL:CAMBI
0.588x
Mangalore Chemicals & Fertilizers Limited
NSE:MANGCHEFER
0.255x
Kunshan Asia Aroma Corp. Ltd.
SHE:301220
0.002x
PTG Energy PCL
BK:PTG
0.112x

Annual Cash Flow Conversion Efficiency for Guanhao Biotech Co Ltd (2007–2025)

The table below shows the annual cash flow conversion efficiency of Guanhao Biotech Co Ltd from 2007 to 2025. Review free cash flow generation of Guanhao Biotech Co Ltd to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥506.03 Million
≈ $74.05 Million
CN¥71.47 Million
≈ $10.46 Million
0.141x +33.28%
2024-12-31 CN¥467.59 Million
≈ $68.42 Million
CN¥49.55 Million
≈ $7.25 Million
0.106x -10.70%
2023-12-31 CN¥456.26 Million
≈ $66.77 Million
CN¥54.15 Million
≈ $7.92 Million
0.119x -27.96%
2022-12-31 CN¥430.88 Million
≈ $63.05 Million
CN¥70.98 Million
≈ $10.39 Million
0.165x +0.70%
2021-12-31 CN¥748.16 Million
≈ $109.48 Million
CN¥122.39 Million
≈ $17.91 Million
0.164x +12.91%
2020-12-31 CN¥716.66 Million
≈ $104.87 Million
CN¥103.84 Million
≈ $15.19 Million
0.145x +10.24%
2019-12-31 CN¥704.14 Million
≈ $103.04 Million
CN¥92.55 Million
≈ $13.54 Million
0.131x +370.53%
2018-12-31 CN¥1.16 Billion
≈ $169.08 Million
CN¥32.28 Million
≈ $4.72 Million
0.028x +76.29%
2017-12-31 CN¥1.21 Billion
≈ $177.49 Million
CN¥19.22 Million
≈ $2.81 Million
0.016x -24.74%
2016-12-31 CN¥1.46 Billion
≈ $213.26 Million
CN¥30.68 Million
≈ $4.49 Million
0.021x -80.75%
2015-12-31 CN¥620.62 Million
≈ $90.82 Million
CN¥67.87 Million
≈ $9.93 Million
0.109x -11.18%
2014-12-31 CN¥531.61 Million
≈ $77.79 Million
CN¥65.45 Million
≈ $9.58 Million
0.123x +47.83%
2013-12-31 CN¥498.16 Million
≈ $72.90 Million
CN¥41.49 Million
≈ $6.07 Million
0.083x -23.01%
2012-12-31 CN¥454.11 Million
≈ $66.45 Million
CN¥49.12 Million
≈ $7.19 Million
0.108x +32.06%
2011-12-31 CN¥432.79 Million
≈ $63.33 Million
CN¥35.45 Million
≈ $5.19 Million
0.082x -64.81%
2010-12-31 CN¥144.99 Million
≈ $21.22 Million
CN¥33.76 Million
≈ $4.94 Million
0.233x +222.72%
2009-12-31 CN¥76.95 Million
≈ $11.26 Million
CN¥5.55 Million
≈ $812.33K
0.072x -44.41%
2008-12-31 CN¥37.01 Million
≈ $5.42 Million
CN¥4.80 Million
≈ $702.80K
0.130x +55.21%
2007-12-31 CN¥20.67 Million
≈ $3.02 Million
CN¥1.73 Million
≈ $252.86K
0.084x --

About Guanhao Biotech Co Ltd

SHE:300238 China Biotechnology
Market Cap
$395.77 Million
CN¥2.70 Billion CNY
Market Cap Rank
#13098 Global
#3831 in China
Share Price
CN¥10.20
Change (1 day)
-1.64%
52-Week Range
CN¥10.20 - CN¥17.85
All Time High
CN¥56.32
About

Guanhao Biotech Co.,Ltd. develops, manufactures, and sells regenerative medicines and life sciences products in China. It offers NormalGEN and GrandNeuro, both a dura repair patch; ThormalGEN, a surgical patch; DermalGEN, a wound dressing product; IREAL breast patch; and Youvision corneal graft, as well as license in intraocular lenses. The company also provides Biological dura, a spinal patch; T… Read more